Would I Lie to You?

Would I Lie to You?

Up next

Nvidia’s Spy Drama, Iran War Status, and Where Conservative Evangelicals Go From Here

This week, AI chipmaker Nvidia opened an investigation into its CEO Jensen Huang’s affair with an alleged Chinese spy. National security expert and author Elizabeth Neumann joins the show to break down the AI/spy saga and its ramifications for the U.S. Then, retired U.S. Army Spe ...  Show more

Blue Tsunami Midterms, Israel’s Election, Latest Religious Liberty Case, and You Can See Everything

Voters showed their true colors in Tuesday’s elections, triggering what most are referring to as a “Blue Tsunami” in the massive overhaul of House and Senate seats as Democrats take the majority. With Peter Wehner as our first guest, we’re diving into the potential implications o ...  Show more

Recommended Episodes

The world after Ozempic
The Gray Area with Sean Illing

Ozempic and other new weight loss drugs are being touted as potential miracle cures for diabetes and obesity. Journalist Johann Hari experimented with the drug and dropped 40 pounds. In his new book, Magic Pill, Hari discusses his experience with Ozempic and speaks to many of the ...  Show more

615. Is Ozempic as Magical as It Sounds?
Freakonomics Radio

In a wide-ranging conversation with Ezekiel Emanuel, the policymaking physician and medical gadfly, we discuss the massive effects of GLP-1 drugs like Ozempic, Wegovy, and Mounjaro. We also talk about the state of cancer care, mysteries in the gut microbiome, flaws in the U.S. ...

  Show more

Ozempic: Weight Loss Miracle Drug or Something Darker? Johann Hari on The Benefits & Risks
The Rich Roll Podcast

This week, I’m joined by Johann Hari, New York Times bestselling author, journalist, and speaker, to explore his journey into the world of the new weight loss drug phenomenon: Ozempic. Johann shares his surprising firsthand experience injecting himself weekly with the drug for ov ...  Show more